{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 1b\/2 Basket Study of ACR-368 as Monotherapy and in Combination with Gemcitabine in Adult Subjects with Platinum-Resistant Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma Based on Acrivon OncoSignature\u00ae Status","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-1b-2-basket-study-of-acr-368-as-monotherapy-and-in-combination-with-gemcitabine-in-adult-subjects-with-platinum-resistant-ovarian-carcinoma-endometrial-adenocarcinoma-and-urothelial-carcinom\/#breadcrumbitem"}]}